Letter Reveals EU Fight Over Toxic Chemicals

European chemical companies have warned the watchdog that oversees them that it could face legal action if it publishes the names of manufacturers of the most toxic substances in a growing environmental dispute.

The warning was contained in a letter from chemical industry group Cefic to the European Chemicals Agency (ECHA) in Helsinki, released after Reuters invoked freedom-of-information laws.

"Going beyond its remits exposes unnecessarily the ECHA Management Board and its individual members to tremendous and unprecedented liability risks," said the letter, seen by Reuters on Wednesday.

ECHA is charged with evaluating and restricting over 30,000 substances that currently face little regulatory oversight, many of them a potential risk to human health.

Companies that want to sell chemicals must register them with ECHA, including details on toxicity, which the agency will publish on its website.

Activist lawyers ClientEarth and chemicals campaigners ChemSec this week said they had sued ECHA for refusing to disclose the names of facilities producing 356 potentially dangerous chemicals.

"The public knows too little about them, because chemicals companies use the shield of commercial interests," said ClientEarth lawyer Vito Buonsante.

Chemicals companies argue publishing the names will endanger their commercial confidentiality and was not intended when the control laws were agreed in 2007.

Statement Of Fact
Cefic denies it is threatening the agency or using unreasonable pressure and says it is merely stating a fact.

"It is calling an authority on its responsibilities," Cefic's legal chief Jean Claude Lahaut told Reuters. "If a company suffered damage...we could indeed have people complaining to the court of justice."

Cefic says the publishing of company names might help overseas rivals compile a detailed picture of the European chemicals market, and reveal changes of company strategy or innovation of new products.

ECHA told Reuters it had decided to publish company names only in the case of firms that are suppliers of hazardous substances, but that they could request confidentiality.

"We had two years of discussions," said ECHA's Christel Musset. "The industry was totally part of our discussions. We also took legal advice from the European Commission."

Anti-toxics campaigners say company details help them hold companies to account for the quality of the toxics data they submit - a serious issue for the health of factory workers.

Cefic says there are better legal tools for the job. "There are permitting systems... you have occupational health legislation," said Lahaut.

ClientEarth's Buonsante said more transparency would encourage companies to replace toxics with safer alternatives.

"Companies would not have this incentive if nobody knew who is responsible for marketing them," he said.

Cefic counters that naming facilities carries other risks.

"We should underline the increase of risks for potential activist and terrorist actions," it said in an explanatory document sent with the letter to ECHA.

Free Virtual Event

ProteiNext 2025

ProteiNext 2025

ProteiNext is an annual symposium that offers a platform for sharing insights on protein analysis

Interview

Fostering Innovation and Collaboration
Specialty Chemicals Distributor IMCD’s Strategy

Fostering Innovation and Collaboration

Valerie Diele-Braun, CEO of IMCD, shares her vision for sustainability, global expansions, and strategic direction in an exclusive CHEManager International interview.

most read

Photo
24.01.2025 • News

And the Winners are: Cynio, EnaDyne and Green Li-ion

The CHEManager Innovation Pitch, the start-up promotion initiative of CHEManager and CHEManager International, has given more than 100 start-ups from over 15 countries the opportunity to present their innovative ideas, products and technologies to a broad target group since its launch in 2019.

Photo
08.11.2024 • News

Future Prospects in Green Chemistry

The Discourse on Green Chemistry Interactive Pitch Competition, held on November 5, 2024, at Wiley's Berlin office as part of Berlin Science Week, showcased a range of innovative projects aimed at addressing critical environmental challenges.

Photo
29.10.2024 • News

GSK to Invest $800 Million in US Manufacturing Facility

British pharma company GlaxoSmithKline (GSK) plans to invest up to $800 million to expand drug substance and drug product manufacturing capabilities at the company’s US site in Marietta, Pennsylvania. The investment, which GSK said is its largest ever in US manufacturing, is expected to create more than 200 new jobs.